The rapid development of a range of COVID-19 vaccines during the pandemic has renewed interest in public-private partnerships. For example, governments and international agencies have partnered with private pharmaceutical companies to fund research and development programmes. This webinar focuses on where these partnerships have come from, whether they have incorporated knowledge from previous outbreak management initiatives, what challenges they have faced and how this experience can shape future public-private partnerships for healthcare R&D.